Apotex Generic Paxil Priced At 7% Discount Following “At Risk” Launch
Executive Summary
Apotex is relying on a district court ruling of noninfringement in launching the first generic of GlaxoSmithKline's antidepressant Paxil (paroxetine)
You may also be interested in...
Zyprexa Patent Valid: Lilly’s Phase I Olanzapine Trials Were Not “Public Use”
Lilly's conduct of Phase I clinical trials for Zyprexa prior to applying for a composition/use patent did not constitute a prior "public use" that would render the patent invalid, an Indianapolis federal judge ruled April 14
Zyprexa Patent Valid: Lilly’s Phase I Olanzapine Trials Were Not “Public Use”
Lilly's conduct of Phase I clinical trials for Zyprexa prior to applying for a composition/use patent did not constitute a prior "public use" that would render the patent invalid, an Indianapolis federal judge ruled April 14
Mylan Takes “Authorized” Generics Fight To Congress, FTC, Courts
Mylan is taking its fight against "authorized" generics beyond FDA to Capitol Hill, the Federal Trade Commission and the federal courts